<DOC>
	<DOCNO>NCT01933048</DOCNO>
	<brief_summary>The purpose prospective , open-label clinical trial evaluate immunogenicity self-administered ( SA ) live , attenuated influenza vaccine ( LAIV ) comparison healthcare worker administer ( HCWA ) LAIV evaluate feasibility group self-administration LAIV .</brief_summary>
	<brief_title>Self-Administered Nasal Influenza Feasibility Study</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<criteria>Healthy male healthy , nonpregnant female 1849 year age Department Defense beneficiary include active duty member Able speak understand English , provide write informed consent Known hypersensitivity egg , eggproteins , gentamicin , gelatin , arginine lifethreatening reaction previous influenza vaccination Prior receipt 20122013 seasonal influenza vaccine 20122013 season prior receipt 20132014 seasonal influenza vaccine 20132014 season Known clinical diagnosis reactive airway disease , wheeze , asthma ( exclude exerciseinduced asthma ) Reported febrile upper respiratory illness ( oral tympanic temperature great 100°F subjective fever ) time within 24 hour prior immunization Known pregnant , possibly pregnant breastfeed Known diagnosis human immunodeficiency virus ( HIV ) infection , chronic active hepatitis B infection , chronic hepatitis C infection History GuillainBarre Syndrome Household member know immunocompromised ( either know disease disorder HIV , acquire congenital immunodeficiency disorder , take systemic steroid ( dose ) high daily dose inhaled steroid , tumor necrosis factoralpha inhibitor , monoclonal antibody use treat autoimmune disease ) Receipt medication activity influenza A and/or B ( ex : Tamiflu® , Relenza® , amantadine , rimantadine ) within 48 hour prior vaccine administration Use oral intravenous systemic steroid ( dose ) daily dose inhaled steroid At time enrollment , person train administer intranasal vaccine involve recur role associate administration intranasal vaccines others clinic military treatment facility ( MTF ) Prior participation research study Any acute chronic medical condition , opinion investigator , would render vaccination unsafe , interfere evaluation response , render subject unable meet requirement protocol . These condition may include , limited : history significant renal impairment ( dialysis treatment kidney disease , include diabetic hypertensive kidney disease ) ; poorly control diabetes mellitus patient diabetes mellitus insulin ( subject wellcontrolled diabetes mellitus oral agent may enroll long dosage increase within past 6 month ) ; cardiac insufficiency , heart failure present ; arteriosclerotic event 6 month prior enrollment ( e.g. , history myocardial infarction , stroke , recanalization femoral artery , transient ischemic attack ) . If individual receive live virus vaccine ( e.g. , Varicella , MeaslesMumpsRubella , Yellow Fever , Smallpox ) past 4 week , wait 28 day receive LAIV . There reason defer vaccination individual vaccinate inactivated vaccine recently receive blood antibodycontaining blood product .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>influenza</keyword>
</DOC>